Thermo Fisher Scientific is nearing a deal for Solventum’s purification and filtration business, according to people familiar ...

Thermo Fisher Scientific Inc. (NYSE: TMO) has struck a deal with Solventum (NYSE: SOLV) to buy its purification and ...

part of the PPD™ clinical research business of Thermo Fisher Scientific. “High-quality, real-world data can drive much-needed insights on novel treatments and provide hope for patients ...

FY’24 results showcase growth potential with 12% IRR, strategic acquisitions, and undervalued stock. Read more on TMO stock ...

This is the 12 th independent registry from CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific. It complements an existing CorEvitas registry focused on AA in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of ...

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective ...

including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com. PharmiWeb.com is Europe's ...